Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 1
2021 1
2022 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population.
Pinpathomrat N, Intapiboon P, Seepathomnarong P, Ongarj J, Sophonmanee R, Hengprakop J, Surasombatpattana S, Uppanisakorn S, Mahasirimongkol S, Sawaengdee W, Phumiamorn S, Sapsutthipas S, Kongkamol C, Ingviya T, Sangsupawanich P, Chusri S. Pinpathomrat N, et al. Among authors: uppanisakorn s. NPJ Vaccines. 2022 May 13;7(1):52. doi: 10.1038/s41541-022-00475-z. NPJ Vaccines. 2022. PMID: 35562372 Free PMC article.
Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population.
Pinpathomrat N, Intapiboon P, Seepathomnarong P, Ongarj J, Sophonmanee R, Hengprakop J, Surasombatpattana S, Uppanisakorn S, Mahasirimongkol S, Sawaengdee W, Phumiamorn S, Sapsutthipas S, Kongkamol C, Ingviya T, Sangsupawanich P, Chusri S. Pinpathomrat N, et al. Among authors: uppanisakorn s. NPJ Vaccines. 2022 Sep 6;7(1):107. doi: 10.1038/s41541-022-00529-2. NPJ Vaccines. 2022. PMID: 36068243 Free PMC article. No abstract available.
T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine.
Sophonmanee R, Ongarj J, Seeyankem B, Seepathomnarong P, Intapiboon P, Surasombatpattana S, Uppanisakorn S, Sangsupawanich P, Chusri S, Pinpathomrat N. Sophonmanee R, et al. Among authors: uppanisakorn s. Vaccines (Basel). 2022 Sep 7;10(9):1494. doi: 10.3390/vaccines10091494. Vaccines (Basel). 2022. PMID: 36146571 Free PMC article.
The incidence of phlebitis development of high concentration of continuous amiodarone infusion with in-line filter compared to the low concentration without in-line filter: a retrospective propensity score-matched analysis.
Cheewatanakornkul S, Vattanaprasan P, Uppanisakorn S, Bhurayanontachai R. Cheewatanakornkul S, et al. Among authors: uppanisakorn s. Acute Crit Care. 2022 Aug;37(3):391-397. doi: 10.4266/acc.2022.00080. Epub 2022 Aug 5. Acute Crit Care. 2022. PMID: 35977899 Free PMC article.
Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population.
Intapiboon P, Seepathomnarong P, Ongarj J, Surasombatpattana S, Uppanisakorn S, Mahasirimongkol S, Sawaengdee W, Phumiamorn S, Sapsutthipas S, Sangsupawanich P, Chusri S, Pinpathomrat N. Intapiboon P, et al. Among authors: uppanisakorn s. Vaccines (Basel). 2021 Nov 23;9(12):1375. doi: 10.3390/vaccines9121375. Vaccines (Basel). 2021. PMID: 34960122 Free PMC article.